Glatiramer acetate-related anaphylaxis may be a delayed reaction

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2024年 / 2023卷 / 1期
关键词：
D O I：
10.1007/s40278-024-65601-8
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2 / 2
相关论文
共 50 条
  • [31] Continuous Intravenous Administration of Adrenaline May Prevent the Biphasic Reaction of Anaphylaxis
    Fujizuka, Kenji
    Nakano, Minoru
    Nakamura, Mitsunobu
    Ogura, Takayuki
    CIRCULATION, 2014, 130
  • [32] Atypical Post-Injection Reactions with Delayed Onset Following Glatiramer Acetate 40 mg: Need for Titration?
    Chiara Zecca
    G. Bellavia
    L. Brambilla
    L. P. Gutierrez
    C. Gerardi
    A. M. Fiori
    L. R. Bernardini
    G. Camera
    G. Disanto
    L. Petrini
    J. Perugini
    C. G. Antozzi
    V. Torri Clerici
    A. Bellino
    P. A. Confalonieri
    C. Gobbi
    R. E. Mantegazza
    S. Rossi
    CNS Drugs, 2018, 32 : 653 - 660
  • [33] Age-Related Changes in the Pattern Electroretinogram of Normal and Glatiramer Acetate-Immunized Rats
    Sandalon, Shai
    Ofri, Ron
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2012, 53 (10) : 6532 - 6540
  • [34] Glatiramer acetate (Copaxone®) regulates nitric oxide and related cytokine secretion in experimental autoimmune encephalomyelitis
    Kayhan, B
    Aharoni, R
    Arnon, R
    IMMUNOLOGY LETTERS, 2003, 88 (03) : 185 - 192
  • [35] DELAYED IGE-MEDIATED REACTION TO LEVAMISOLE: EVALUATION OF A PATIENT WITH SEVERE ANAPHYLAXIS
    Siatoya, W. Garzon
    Carrillo-Martin, I.
    Rodenas, M.
    Gonzalez-Estrada, A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (05) : S64 - S65
  • [36] Anaphylactic Reaction after Injection of Glatiramer Acetate (Copaxone®) in Patients with Relapsing-Remitting Multiple Sclerosis
    Baumgartner, Annette
    Stich, Oliver
    Rauer, Sebastian
    EUROPEAN NEUROLOGY, 2011, 66 (06) : 368 - 370
  • [37] Fingolimod/Glatiramer-acetate/SteroidsInjection site reaction, lack of efficacy and treatment noncompliance: case report
    Reactions Weekly, 2024, 2023 (1) : 173 - 173
  • [38] Glatiramer acetate (Copaxone): comparison of continuous versus delayed therapy in a six-year organized multiple sclerosis trial
    Johnson, KP
    Brooks, BR
    Ford, CC
    Goodman, AD
    Lisak, RP
    Myers, LW
    Pruitt, AA
    Rizzo, MA
    Rose, JW
    Weiner, LP
    Wolinsky, JS
    MULTIPLE SCLEROSIS, 2003, 9 (06): : 585 - 591
  • [39] Weekly Vaccination with Copaxone (Glatiramer Acetate) as a Potential Therapy for Dry Age-Related Macular Degeneration
    Landa, Gennady
    Butovsky, Oleg
    Shoshani, Johai
    Schwartz, Michal
    Pollack, Ayala
    CURRENT EYE RESEARCH, 2008, 33 (11-12) : 1011 - 1013
  • [40] Expression profiling identifies genes related to glatiramer acetate activity in peripheral blood of multiple sclerosis patients
    Achiron, A
    Snir, Y
    Sonis, R
    Gurevich, M
    MULTIPLE SCLEROSIS, 2005, 11 : S11 - S11
12345